KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- Small Doses: April 29 to May 3 May 4, 2024Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.
- FDA Roundup: Humira Biosimilar, WHIM Syndrome Treatment May 3, 2024Check out important updates from the FDA for the week of April 29.
- Video: The Inflation Reduction Act in 2024 and Beyond May 3, 2024A lack of clarity around certain provisions of the Inflation Reduction Act has presented challenges to payers.
- Brexpiprazole Plus Sertraline for PTSD Submitted to FDA for sNDA Review May 3, 2024Two trials studying brexpiprazole in combination with sertraline "constitute one of the largest clinical development programs ever conducted in posttraumatic stress disorder (PTSD)."
- OTC Product Roundup: In a Galaxy Far, Far Away… May 3, 2024Are you a Wookie with a mane to maintain or a scoundrel prone to nausea? You don’t have to traverse distant planets to find OTC recommendations that meet your needs—this guide has you covered.
- Q&A: Inside the Vanderbilt Specialty Pharmacy-AstraZeneca Collaboration May 2, 2024A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.
- Pharmacogenetic Testing Recommendations Needed in Clinical Guidelines to Increase Consistency May 2, 2024A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.
- Goal Alignment Improves Pharmacist-Manufacturer Collaborations, Care May 2, 2024Understanding the goals of each party is the first step to a successful collaboration.
- Real World Data Show That Pharmacist-Manufacturer Collaboration Improves Patient Outcomes May 2, 2024Collaboration between health system specialty pharmacists and pharmaceutical manufacturers can benefit patients in the long run.
- Siloed Systems Hinder Patient Care May 2, 2024Collaboration between health system specialty pharmacies and manufacturers can benefit patients in the long run.
Pharmacy Times articles
- Women During Perimenopause Are More Likely to Experience Depression, Study Finds May 4, 2024Compared with women who aren’t experiencing menopausal symptoms, women in the perimenopause stage were approximately 40% more likely to experience depressive symptoms.
- Study Finds Similar COVID-19 Vaccination Rates in Undocumented Latinx Patients and US Citizens May 3, 2024Additionally, undocumented Latinx patients were also more likely to have at least 1 prior COVID-19 infection.
- Study Finds Non-Hispanic African American Patients Have Worse allo-, autoHCT Outcomes May 3, 2024Despite the increased survival rates in all 4 evaluated racial groups, both adult and pediatric non-Hispanic African American patients continued to have worse outcomes.
- Expert: The Role of Pharmacists in Optimizing Prostate Cancer Care May 3, 2024Scott Soefje discusses new treatment options for prostate cancer and highlights the important role pharmacists can play in coordinating care.
- Understanding State Regulations and Advocating for Medically Integrated Dispensing May 3, 2024Christie Smith discusses navigating state pharmacy laws and advocating for policy changes to improve patient access and care coordination.
- Integrating Technicians in Reimbursement Requires Understanding CPT Codes May 3, 2024By empowering pharmacy technicians to actively participate in billing and reimbursement processes, health care practices can streamline operations, mitigate billing errors, and optimize revenue generation.
- In Addition to Workload and Staffing, Automation Can Help Pharmacies Tackle Pricing Pressures May 3, 2024Automation has long been viewed as a tool to help improving staffing and workload, but Swanson said it can help a multitude of other challenges, as well.
- Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab May 3, 2024The results reinforce other real-world evidence from several broad infant immunization programs in the US, Spain, and France.
- Bridging the Gap: How Pharmacists Can Expand and Transform Mental Health Services May 3, 2024This expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.
- Dr. Reddy's Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S. May 3, 2024
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com